Effect of ouabain on relaxation induced by cromakalim in human and canine mesenteric arteries.
We investigated the effect of cromakalim, a K+ channel opener, that activates indirectly the Na(+)-K+ pump, in association with increased K+ conductance in the mesenteric arteries. In 65% of human mesenteric arteries tested, the concentration-dependent relaxation curves for cromakalim were biphasic: the low concentration (< 10(-7) M) effect was preferentially inhibited by ouabain, whereas the higher concentration effect was significantly inhibited by glibenclamide. In branches of canine mesenteric artery, the cromakalim-induced relaxation was inhibited by pretreatment with ouabain (1 microM) as well as by glibenclamide (1 microM). The reduction in contraction of human and canine mesenteric arterial strips caused by cromakalim was totally reversed by pretreatment with ouabain (1 microM) or glibenclamide (1 microM). On the other hand, in canine mesenteric artery, cromakalim caused a significant stimulation of 22Na+ influx and ouabain-sensitive 86Rb+ uptake in association with increased 86Rb+ efflux, all of which were inhibited by glibenclamide (1 microM). Thus, it is suggested that cromakalim possesses the additional property to stimulate the Na(+)-K+ pump through an elevation in intracellular Na+, resulting in strong relaxation of blood vessels.
Department of Pharmacology, College of Medicine, Pusan National University, Korea.
K W
KW
Hong
M G
MG
Park
Y W
YW
Shin
B Y
BY
Rhim
K H
KH
Ko
D000328:Adult; D000818:Animals; D001578:Benzopyrans / Q000037:antagonists & inhibitors*; D019806:Cromakalim; D004285:Dogs; D005260:Female; D005905:Glyburide / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology*; D011758:Pyrroles / Q000037:antagonists & inhibitors*; D012414:Rubidium Radioisotopes; D012680:Sensitivity and Specificity; D012979:Sodium Radioisotopes; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects*; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors*
D001578:Benzopyrans; D011758:Pyrroles; D012414:Rubidium Radioisotopes; D012979:Sodium Radioisotopes; D014665:Vasodilator Agents; D019806:Cromakalim; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase; D005905:Glyburide